Approval · Notice of Compliance 34623 · 2024
VIVOTIF: Notice of Compliance 34623
Issued December 13, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34623
- Date
- December 13, 2024
- Company
- Bavarian Nordic AsHellerup, --, Denmark
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to inner and outer labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIVOTIF | Not yet assigned | — |
Medicinal ingredients
- TYPHOID VACCINE LIVE ORAL ATTENUATED TY21A 10 B per CAP